Skip to main content

Day: August 9, 2022

Solid Waste Management Market Size to Hit USD 366.52 Billion by 2027 | Exhibit a CAGR of 3.3% (2020-2027)

According to Fortune Business Insights, the global solid waste management market size was USD 285.16 billion in 2019 and is projected to reach USD 366.52 billion by 2027, exhibiting a CAGR of 3.3% during the forecast period, 2020-2027 | Europe Emerged Dominant Owing to High Collection Rate from Nations Pune, India, Aug. 09, 2022 (GLOBE NEWSWIRE) — The global solid waste management market size is projected to gain traction on account of the increasing amount of waste generation, further attributed to the contributions of the residential, commercial, and industrial sectors. Solid waste majorly includes waste plastic products, organic matter, and metal and glass products. The forecast period is set between 2020 to 2027, and the market is likely to exhibit a CAGR of 3.3%. As per a recent report by Fortune Business Insights, titled,...

Continue reading

Acrylic Resins Market Size Hit USD 28,051.3 Million by 2028 | Exhibit a CAGR of 4.8% (2021-2028)

According to Fortune Business Insights, the global acrylic resins market Size is projected to reach USD 28,051.3 Million in 2028, at CAGR of 4.8% during forecast period 2021-2028 | Increasing Demand for Antimicrobial Coatings to Propel Market Growth Pune, India, Aug. 09, 2022 (GLOBE NEWSWIRE) — The global acrylic resins market size is expected to experience considerable growth by reaching USD 28,051.3 million by 2028 while exhibiting a CAGR of 4.8% between 2021 and 2028. This information is published by Fortune Business Insights in its latest report, titled “Acrylic Resins Market, 2021-2028.” The report further mentions that the market stood at USD 19,115.9 million in 2020. Factors such as the increasing demand for antimicrobial coatings will boost the product’s demand during the forecast period. Moreover, the rising construction...

Continue reading

Automatic Weapons Market Size Hit USD 15.04 Billion by 2027 | Automatic Weapons Industry High Growth in United States, Russia, China, Germany, Israel, and ROW

According to Fortune Business Insights, the global automatic weapons market size is projected to reach USD 15.04 Billion by 2027, at CAGR of 7.85% during forecast period 2020-2027 | Rising Spend on Défense Budget to Augment Growth Pune, India, Aug. 09, 2022 (GLOBE NEWSWIRE) — The global automatic weapons market size is expected to reach USD 15.04 billion by 2027. This is attributable to the increasing demand for advanced automatic weapons and the rising defense budget of nations across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Automatic Weapons Market Size, Share & Industry Analysis, and Regional Forecast, 2020-2027.” The report mentions that the market stood at USD 8.44 billion in 2019 and is likely to exhibit a CAGR of 7.85% between 2020 and 2027. Get a Sample PDF...

Continue reading

Meat Substitute Market to Reach USD 12.30 Billion by 2029 | Europe to Gain Ground from Rising Popularity of Plant-based Products

According to Fortune Business Insights, the meat substitute market size was valued at USD 5.41 billion in 2021. The market is projected to grow from USD 5.88 billion in 2022 to USD 12.30 billion by 2029, exhibiting a CAGR of 11.11% during the forecast period 2022-2029. Pune, India, Aug. 09, 2022 (GLOBE NEWSWIRE) — The global meat substitute market size was valued at USD 5.41 billion in 2021. The market is anticipated to surge from USD 5.88 billion in 2022 to USD 12.30 billion by 2029 at an 11.11% CAGR during the forecast period. Fortune Business Insights™ has deep-dived these inputs in its latest research report, titled, “Meat Substitute Market, 2022-2029.” According to the study, plant-based products have become sought-after in minimizing the issues of dependence on livestock production for meat products. Clean meat substitute...

Continue reading

GlobalFoundries Reports Second Quarter 2022 Financial Results

Record Revenue, Gross Profit, and Net Income MALTA, N.Y., Aug. 09, 2022 (GLOBE NEWSWIRE) — GlobalFoundries Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the second quarter ended June 30, 2022. Key Second Quarter Financial HighlightsRecord revenue of $1.99 billion, up 23% year-over-year. Record gross margin of 27.0% and adjusted gross margin of 28.0%. Record operating margin of 14.9% and adjusted operating margin of 17.6%. Record net income of $264 million and adjusted net income of $317 million. Record adjusted EBITDA margin of 39.3%. Cash and cash equivalents and marketable securities of $3.3 billion.“In the second quarter, the GF team delivered on its commitments to customers and shareholders,” said CEO Dr. Thomas Caulfield. “We shipped a record 630 thousand wafers in the quarter, driven...

Continue reading

Interim report of Copenhagen Airports A/S (CPH) for the period 1 January – 30 June 2022

Stock Exchange Announcement Copenhagen, 9 August 2022 The Board of Directors has today approved the interim report for the period 1 January – 30 June 2022. HIGHLIGHTSThe number of passengers at Copenhagen Airports was 9.4 million in the first half of 2022, an increase of 8 million compared with the first half of 2021. The number of locally departing passengers was 4 million (535.5% up from last year), 4.7 million were arriving passengers (598.2% up from last year), and 0.7 million were departing transfer passengers (759% up from last year). Total passengers in H1 2019 were 14.4 million.Revenue amounted to DKK 1,550 million (H1 2021: DKK 448 million), an increase of 246% compared with H1 2021 driven by higher passenger numbers.EBITDA was positive at DKK 550 million (H1 2021: loss of DKK 265 million), up by DKK 815 million on last...

Continue reading

Rule 8.3 – Emis Group

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Investec Wealth & Investment Limited(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeEmis Group Plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)        Date...

Continue reading

ROBIT PLC HALF-YEAR REPORT 1 JANUARY–30 JUNE 2022: RECORD NET SALES, PROFITABILITY IMPROVED 

ROBIT PLC          STOCK EXCHANGE RELEASE          09/08/2022 at 11:00 am ROBIT PLC HALF-YEAR REPORT 1 JANUARY–30 JUNE 2022: RECORD NET SALES, PROFITABILITY IMPROVED  In the text, ‘review period’ refers to 1 April–30 June 2022 (Q2), and ‘H1’ refers to 1 January–30 June 2022. Figures from the corresponding time period in 2021 are given in parentheses. All the figures presented are in euros. Percentages are calculated from thousands of euros. 1 April–30 June 2022 in briefNet sales EUR 31.0 million (25.1), increase 23.7% EBITDA EUR 4.1 million (1.9) EBITDA 13.1% of net sales (7.4%) EBITA EUR 2.8 million (0.7) EBIT 8.4% of net sales (1.8%) Review period net income EUR 2.1 million (-0.2) Net cash flow from operating activities EUR 1.4 million (-2.4)1 January–30 June 2022 in briefNet sales EUR 57.3 million (48.1), increase 19.2% EBITDA...

Continue reading

Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Ensifentrine met primary and secondary endpoints of evaluating lung function in Phase 3 ENHANCE-2 trial for COPD Top-line Phase 3 ENHANCE-1 data expected around the end of 2022 Conference call today at 8:30 a.m. EDT / 1:30 p.m. BST LONDON and RALEIGH, N.C., Aug. 09, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended June 30, 2022, and provides a corporate update. In a separate press release issued earlier today, Verona Pharma announced positive top-line results from its Phase 3 ENHANCE-2 (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) trial evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease...

Continue reading

Construction contract in Estonia (tram line connecting Old Harbour and Rail Baltic’s Ülemiste passenger terminal in Tallinn)

On 9 August 2022, AS Merko Ehitus Eesti, part of AS Merko Ehitus group, and KMG Inseneriehituse AS signed a design and construction contract with Tallinn Urban Environment and Public Works Department for the construction of a tram line connecting the Tallinn Old Harbour with Rail Baltic’s Ülemiste passenger terminal. About being selected the preferred bidder, AS Merko Ehitus published stock exchange announcement on 19 July 2022. Under the agreement, a new tram line will be built on a section of approximately 2.5 kilometres, starting at the intersection of Kivisilla/Gonsiori streets up to the Põhja boulevard. In carrying out the works, AS Merko Ehitus Eesti is the leading partner with a 50:50 ratio. The contract value is approximately EUR 36.5 million, plus value added tax. The scheduled deadline of the works is in February 2025. AS Merko...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.